Global Immune Globulin Intravenous Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Immune Globulin Intravenous market size was valued at USD 13750 million in 2023 and is forecast to a readjusted size of USD 21780 million by 2030 with a CAGR of 6.8% during review period.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
The Global Info Research report includes an overview of the development of the Immune Globulin Intravenous industry chain, the market status of Immunodeficiency (IVIg Liquid, IVIg Powder), Autoimmune Disease (IVIg Liquid, IVIg Powder), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immune Globulin Intravenous.
Regionally, the report analyzes the Immune Globulin Intravenous markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immune Globulin Intravenous market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immune Globulin Intravenous market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immune Globulin Intravenous industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., IVIg Liquid, IVIg Powder).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immune Globulin Intravenous market.
Regional Analysis: The report involves examining the Immune Globulin Intravenous market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immune Globulin Intravenous market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immune Globulin Intravenous:
Company Analysis: Report covers individual Immune Globulin Intravenous manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immune Globulin Intravenous This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunodeficiency, Autoimmune Disease).
Technology Analysis: Report covers specific technologies relevant to Immune Globulin Intravenous. It assesses the current state, advancements, and potential future developments in Immune Globulin Intravenous areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immune Globulin Intravenous market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immune Globulin Intravenous market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Immune Globulin Intravenous product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immune Globulin Intravenous, with price, sales, revenue and global market share of Immune Globulin Intravenous from 2019 to 2024.
Chapter 3, the Immune Globulin Intravenous competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immune Globulin Intravenous breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Immune Globulin Intravenous market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immune Globulin Intravenous.
Chapter 14 and 15, to describe Immune Globulin Intravenous sales channel, distributors, customers, research findings and conclusion.
Immune globulin (Ig) short-term protection against hepatitis A and measles
The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.
The Global Info Research report includes an overview of the development of the Immune Globulin Intravenous industry chain, the market status of Immunodeficiency (IVIg Liquid, IVIg Powder), Autoimmune Disease (IVIg Liquid, IVIg Powder), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immune Globulin Intravenous.
Regionally, the report analyzes the Immune Globulin Intravenous markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immune Globulin Intravenous market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Immune Globulin Intravenous market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immune Globulin Intravenous industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., IVIg Liquid, IVIg Powder).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immune Globulin Intravenous market.
Regional Analysis: The report involves examining the Immune Globulin Intravenous market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immune Globulin Intravenous market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Immune Globulin Intravenous:
Company Analysis: Report covers individual Immune Globulin Intravenous manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immune Globulin Intravenous This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immunodeficiency, Autoimmune Disease).
Technology Analysis: Report covers specific technologies relevant to Immune Globulin Intravenous. It assesses the current state, advancements, and potential future developments in Immune Globulin Intravenous areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immune Globulin Intravenous market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Immune Globulin Intravenous market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- IVIg Liquid
- IVIg Powder
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Takeda
- Grifols
- CSL
- Octapharma
- Biotest
- Kedrion
- Hualan Bio
- CNBG
- Shanghai RAAS
- CBPO
- LFB Group
- BPL
- Sichuan Yuanda Shuyang
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Immune Globulin Intravenous product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immune Globulin Intravenous, with price, sales, revenue and global market share of Immune Globulin Intravenous from 2019 to 2024.
Chapter 3, the Immune Globulin Intravenous competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immune Globulin Intravenous breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Immune Globulin Intravenous market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immune Globulin Intravenous.
Chapter 14 and 15, to describe Immune Globulin Intravenous sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Immune Globulin Intravenous
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immune Globulin Intravenous Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 IVIg Liquid
1.3.3 IVIg Powder
1.4 Market Analysis by Application
1.4.1 Overview: Global Immune Globulin Intravenous Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Immunodeficiency
1.4.3 Autoimmune Disease
1.4.4 Acute Infection
1.5 Global Immune Globulin Intravenous Market Size & Forecast
1.5.1 Global Immune Globulin Intravenous Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Immune Globulin Intravenous Sales Quantity (2019-2030)
1.5.3 Global Immune Globulin Intravenous Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Immune Globulin Intravenous Product and Services
2.1.4 Takeda Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Immune Globulin Intravenous Product and Services
2.2.4 Grifols Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Immune Globulin Intravenous Product and Services
2.3.4 CSL Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Immune Globulin Intravenous Product and Services
2.4.4 Octapharma Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Immune Globulin Intravenous Product and Services
2.5.4 Biotest Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Biotest Recent Developments/Updates
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Immune Globulin Intravenous Product and Services
2.6.4 Kedrion Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Kedrion Recent Developments/Updates
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Immune Globulin Intravenous Product and Services
2.7.4 Hualan Bio Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Bio Recent Developments/Updates
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Immune Globulin Intravenous Product and Services
2.8.4 CNBG Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 CNBG Recent Developments/Updates
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Immune Globulin Intravenous Product and Services
2.9.4 Shanghai RAAS Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai RAAS Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Immune Globulin Intravenous Product and Services
2.10.4 CBPO Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CBPO Recent Developments/Updates
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group Immune Globulin Intravenous Product and Services
2.11.4 LFB Group Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 LFB Group Recent Developments/Updates
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL Immune Globulin Intravenous Product and Services
2.12.4 BPL Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 BPL Recent Developments/Updates
2.13 Sichuan Yuanda Shuyang
2.13.1 Sichuan Yuanda Shuyang Details
2.13.2 Sichuan Yuanda Shuyang Major Business
2.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product and Services
2.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNE GLOBULIN INTRAVENOUS BY MANUFACTURER
3.1 Global Immune Globulin Intravenous Sales Quantity by Manufacturer (2019-2024)
3.2 Global Immune Globulin Intravenous Revenue by Manufacturer (2019-2024)
3.3 Global Immune Globulin Intravenous Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Immune Globulin Intravenous by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Immune Globulin Intravenous Manufacturer Market Share in 2023
3.4.2 Top 6 Immune Globulin Intravenous Manufacturer Market Share in 2023
3.5 Immune Globulin Intravenous Market: Overall Company Footprint Analysis
3.5.1 Immune Globulin Intravenous Market: Region Footprint
3.5.2 Immune Globulin Intravenous Market: Company Product Type Footprint
3.5.3 Immune Globulin Intravenous Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immune Globulin Intravenous Market Size by Region
4.1.1 Global Immune Globulin Intravenous Sales Quantity by Region (2019-2030)
4.1.2 Global Immune Globulin Intravenous Consumption Value by Region (2019-2030)
4.1.3 Global Immune Globulin Intravenous Average Price by Region (2019-2030)
4.2 North America Immune Globulin Intravenous Consumption Value (2019-2030)
4.3 Europe Immune Globulin Intravenous Consumption Value (2019-2030)
4.4 Asia-Pacific Immune Globulin Intravenous Consumption Value (2019-2030)
4.5 South America Immune Globulin Intravenous Consumption Value (2019-2030)
4.6 Middle East and Africa Immune Globulin Intravenous Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
5.2 Global Immune Globulin Intravenous Consumption Value by Type (2019-2030)
5.3 Global Immune Globulin Intravenous Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
6.2 Global Immune Globulin Intravenous Consumption Value by Application (2019-2030)
6.3 Global Immune Globulin Intravenous Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
7.2 North America Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
7.3 North America Immune Globulin Intravenous Market Size by Country
7.3.1 North America Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
7.3.2 North America Immune Globulin Intravenous Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
8.2 Europe Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
8.3 Europe Immune Globulin Intravenous Market Size by Country
8.3.1 Europe Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
8.3.2 Europe Immune Globulin Intravenous Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Immune Globulin Intravenous Market Size by Region
9.3.1 Asia-Pacific Immune Globulin Intravenous Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Immune Globulin Intravenous Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
10.2 South America Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
10.3 South America Immune Globulin Intravenous Market Size by Country
10.3.1 South America Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
10.3.2 South America Immune Globulin Intravenous Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Immune Globulin Intravenous Market Size by Country
11.3.1 Middle East & Africa Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Immune Globulin Intravenous Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Immune Globulin Intravenous Market Drivers
12.2 Immune Globulin Intravenous Market Restraints
12.3 Immune Globulin Intravenous Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immune Globulin Intravenous and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immune Globulin Intravenous
13.3 Immune Globulin Intravenous Production Process
13.4 Immune Globulin Intravenous Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immune Globulin Intravenous Typical Distributors
14.3 Immune Globulin Intravenous Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Immune Globulin Intravenous
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Immune Globulin Intravenous Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 IVIg Liquid
1.3.3 IVIg Powder
1.4 Market Analysis by Application
1.4.1 Overview: Global Immune Globulin Intravenous Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Immunodeficiency
1.4.3 Autoimmune Disease
1.4.4 Acute Infection
1.5 Global Immune Globulin Intravenous Market Size & Forecast
1.5.1 Global Immune Globulin Intravenous Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Immune Globulin Intravenous Sales Quantity (2019-2030)
1.5.3 Global Immune Globulin Intravenous Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Immune Globulin Intravenous Product and Services
2.1.4 Takeda Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Immune Globulin Intravenous Product and Services
2.2.4 Grifols Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Grifols Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Immune Globulin Intravenous Product and Services
2.3.4 CSL Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 CSL Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Immune Globulin Intravenous Product and Services
2.4.4 Octapharma Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Immune Globulin Intravenous Product and Services
2.5.4 Biotest Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Biotest Recent Developments/Updates
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Immune Globulin Intravenous Product and Services
2.6.4 Kedrion Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Kedrion Recent Developments/Updates
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Immune Globulin Intravenous Product and Services
2.7.4 Hualan Bio Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Hualan Bio Recent Developments/Updates
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Immune Globulin Intravenous Product and Services
2.8.4 CNBG Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 CNBG Recent Developments/Updates
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Immune Globulin Intravenous Product and Services
2.9.4 Shanghai RAAS Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai RAAS Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Immune Globulin Intravenous Product and Services
2.10.4 CBPO Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CBPO Recent Developments/Updates
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group Immune Globulin Intravenous Product and Services
2.11.4 LFB Group Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 LFB Group Recent Developments/Updates
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL Immune Globulin Intravenous Product and Services
2.12.4 BPL Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 BPL Recent Developments/Updates
2.13 Sichuan Yuanda Shuyang
2.13.1 Sichuan Yuanda Shuyang Details
2.13.2 Sichuan Yuanda Shuyang Major Business
2.13.3 Sichuan Yuanda Shuyang Immune Globulin Intravenous Product and Services
2.13.4 Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IMMUNE GLOBULIN INTRAVENOUS BY MANUFACTURER
3.1 Global Immune Globulin Intravenous Sales Quantity by Manufacturer (2019-2024)
3.2 Global Immune Globulin Intravenous Revenue by Manufacturer (2019-2024)
3.3 Global Immune Globulin Intravenous Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Immune Globulin Intravenous by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Immune Globulin Intravenous Manufacturer Market Share in 2023
3.4.2 Top 6 Immune Globulin Intravenous Manufacturer Market Share in 2023
3.5 Immune Globulin Intravenous Market: Overall Company Footprint Analysis
3.5.1 Immune Globulin Intravenous Market: Region Footprint
3.5.2 Immune Globulin Intravenous Market: Company Product Type Footprint
3.5.3 Immune Globulin Intravenous Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Immune Globulin Intravenous Market Size by Region
4.1.1 Global Immune Globulin Intravenous Sales Quantity by Region (2019-2030)
4.1.2 Global Immune Globulin Intravenous Consumption Value by Region (2019-2030)
4.1.3 Global Immune Globulin Intravenous Average Price by Region (2019-2030)
4.2 North America Immune Globulin Intravenous Consumption Value (2019-2030)
4.3 Europe Immune Globulin Intravenous Consumption Value (2019-2030)
4.4 Asia-Pacific Immune Globulin Intravenous Consumption Value (2019-2030)
4.5 South America Immune Globulin Intravenous Consumption Value (2019-2030)
4.6 Middle East and Africa Immune Globulin Intravenous Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
5.2 Global Immune Globulin Intravenous Consumption Value by Type (2019-2030)
5.3 Global Immune Globulin Intravenous Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
6.2 Global Immune Globulin Intravenous Consumption Value by Application (2019-2030)
6.3 Global Immune Globulin Intravenous Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
7.2 North America Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
7.3 North America Immune Globulin Intravenous Market Size by Country
7.3.1 North America Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
7.3.2 North America Immune Globulin Intravenous Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
8.2 Europe Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
8.3 Europe Immune Globulin Intravenous Market Size by Country
8.3.1 Europe Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
8.3.2 Europe Immune Globulin Intravenous Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Immune Globulin Intravenous Market Size by Region
9.3.1 Asia-Pacific Immune Globulin Intravenous Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Immune Globulin Intravenous Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
10.2 South America Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
10.3 South America Immune Globulin Intravenous Market Size by Country
10.3.1 South America Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
10.3.2 South America Immune Globulin Intravenous Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Immune Globulin Intravenous Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Immune Globulin Intravenous Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Immune Globulin Intravenous Market Size by Country
11.3.1 Middle East & Africa Immune Globulin Intravenous Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Immune Globulin Intravenous Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Immune Globulin Intravenous Market Drivers
12.2 Immune Globulin Intravenous Market Restraints
12.3 Immune Globulin Intravenous Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Immune Globulin Intravenous and Key Manufacturers
13.2 Manufacturing Costs Percentage of Immune Globulin Intravenous
13.3 Immune Globulin Intravenous Production Process
13.4 Immune Globulin Intravenous Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Immune Globulin Intravenous Typical Distributors
14.3 Immune Globulin Intravenous Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Immune Globulin Intravenous Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Immune Globulin Intravenous Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Immune Globulin Intravenous Product and Services
Table 6. Takeda Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Immune Globulin Intravenous Product and Services
Table 11. Grifols Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Grifols Recent Developments/Updates
Table 13. CSL Basic Information, Manufacturing Base and Competitors
Table 14. CSL Major Business
Table 15. CSL Immune Globulin Intravenous Product and Services
Table 16. CSL Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CSL Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Immune Globulin Intravenous Product and Services
Table 21. Octapharma Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Biotest Basic Information, Manufacturing Base and Competitors
Table 24. Biotest Major Business
Table 25. Biotest Immune Globulin Intravenous Product and Services
Table 26. Biotest Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Biotest Recent Developments/Updates
Table 28. Kedrion Basic Information, Manufacturing Base and Competitors
Table 29. Kedrion Major Business
Table 30. Kedrion Immune Globulin Intravenous Product and Services
Table 31. Kedrion Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Kedrion Recent Developments/Updates
Table 33. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 34. Hualan Bio Major Business
Table 35. Hualan Bio Immune Globulin Intravenous Product and Services
Table 36. Hualan Bio Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Hualan Bio Recent Developments/Updates
Table 38. CNBG Basic Information, Manufacturing Base and Competitors
Table 39. CNBG Major Business
Table 40. CNBG Immune Globulin Intravenous Product and Services
Table 41. CNBG Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. CNBG Recent Developments/Updates
Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai RAAS Major Business
Table 45. Shanghai RAAS Immune Globulin Intravenous Product and Services
Table 46. Shanghai RAAS Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Shanghai RAAS Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Immune Globulin Intravenous Product and Services
Table 51. CBPO Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CBPO Recent Developments/Updates
Table 53. LFB Group Basic Information, Manufacturing Base and Competitors
Table 54. LFB Group Major Business
Table 55. LFB Group Immune Globulin Intravenous Product and Services
Table 56. LFB Group Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. LFB Group Recent Developments/Updates
Table 58. BPL Basic Information, Manufacturing Base and Competitors
Table 59. BPL Major Business
Table 60. BPL Immune Globulin Intravenous Product and Services
Table 61. BPL Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. BPL Recent Developments/Updates
Table 63. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 64. Sichuan Yuanda Shuyang Major Business
Table 65. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product and Services
Table 66. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 68. Global Immune Globulin Intravenous Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 69. Global Immune Globulin Intravenous Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Immune Globulin Intravenous Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 71. Market Position of Manufacturers in Immune Globulin Intravenous, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Immune Globulin Intravenous Production Site of Key Manufacturer
Table 73. Immune Globulin Intravenous Market: Company Product Type Footprint
Table 74. Immune Globulin Intravenous Market: Company Product Application Footprint
Table 75. Immune Globulin Intravenous New Market Entrants and Barriers to Market Entry
Table 76. Immune Globulin Intravenous Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Immune Globulin Intravenous Sales Quantity by Region (2019-2024) & (K Units)
Table 78. Global Immune Globulin Intravenous Sales Quantity by Region (2025-2030) & (K Units)
Table 79. Global Immune Globulin Intravenous Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Immune Globulin Intravenous Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Immune Globulin Intravenous Average Price by Region (2019-2024) & (USD/Unit)
Table 82. Global Immune Globulin Intravenous Average Price by Region (2025-2030) & (USD/Unit)
Table 83. Global Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Global Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Global Immune Globulin Intravenous Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Immune Globulin Intravenous Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Immune Globulin Intravenous Average Price by Type (2019-2024) & (USD/Unit)
Table 88. Global Immune Globulin Intravenous Average Price by Type (2025-2030) & (USD/Unit)
Table 89. Global Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Global Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Global Immune Globulin Intravenous Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Immune Globulin Intravenous Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Immune Globulin Intravenous Average Price by Application (2019-2024) & (USD/Unit)
Table 94. Global Immune Globulin Intravenous Average Price by Application (2025-2030) & (USD/Unit)
Table 95. North America Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 96. North America Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 97. North America Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 98. North America Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 99. North America Immune Globulin Intravenous Sales Quantity by Country (2019-2024) & (K Units)
Table 100. North America Immune Globulin Intravenous Sales Quantity by Country (2025-2030) & (K Units)
Table 101. North America Immune Globulin Intravenous Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Immune Globulin Intravenous Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Europe Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Europe Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 106. Europe Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 107. Europe Immune Globulin Intravenous Sales Quantity by Country (2019-2024) & (K Units)
Table 108. Europe Immune Globulin Intravenous Sales Quantity by Country (2025-2030) & (K Units)
Table 109. Europe Immune Globulin Intravenous Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Immune Globulin Intravenous Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 112. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 113. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 114. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 115. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Region (2019-2024) & (K Units)
Table 116. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Region (2025-2030) & (K Units)
Table 117. Asia-Pacific Immune Globulin Intravenous Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Immune Globulin Intravenous Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 120. South America Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 121. South America Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 122. South America Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 123. South America Immune Globulin Intravenous Sales Quantity by Country (2019-2024) & (K Units)
Table 124. South America Immune Globulin Intravenous Sales Quantity by Country (2025-2030) & (K Units)
Table 125. South America Immune Globulin Intravenous Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Immune Globulin Intravenous Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 128. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 129. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 130. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 131. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Region (2019-2024) & (K Units)
Table 132. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Region (2025-2030) & (K Units)
Table 133. Middle East & Africa Immune Globulin Intravenous Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Immune Globulin Intravenous Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Immune Globulin Intravenous Raw Material
Table 136. Key Manufacturers of Immune Globulin Intravenous Raw Materials
Table 137. Immune Globulin Intravenous Typical Distributors
Table 138. Immune Globulin Intravenous Typical Customers
Table 1. Global Immune Globulin Intravenous Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Immune Globulin Intravenous Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Immune Globulin Intravenous Product and Services
Table 6. Takeda Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. Grifols Basic Information, Manufacturing Base and Competitors
Table 9. Grifols Major Business
Table 10. Grifols Immune Globulin Intravenous Product and Services
Table 11. Grifols Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Grifols Recent Developments/Updates
Table 13. CSL Basic Information, Manufacturing Base and Competitors
Table 14. CSL Major Business
Table 15. CSL Immune Globulin Intravenous Product and Services
Table 16. CSL Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. CSL Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Immune Globulin Intravenous Product and Services
Table 21. Octapharma Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Biotest Basic Information, Manufacturing Base and Competitors
Table 24. Biotest Major Business
Table 25. Biotest Immune Globulin Intravenous Product and Services
Table 26. Biotest Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Biotest Recent Developments/Updates
Table 28. Kedrion Basic Information, Manufacturing Base and Competitors
Table 29. Kedrion Major Business
Table 30. Kedrion Immune Globulin Intravenous Product and Services
Table 31. Kedrion Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Kedrion Recent Developments/Updates
Table 33. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 34. Hualan Bio Major Business
Table 35. Hualan Bio Immune Globulin Intravenous Product and Services
Table 36. Hualan Bio Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Hualan Bio Recent Developments/Updates
Table 38. CNBG Basic Information, Manufacturing Base and Competitors
Table 39. CNBG Major Business
Table 40. CNBG Immune Globulin Intravenous Product and Services
Table 41. CNBG Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. CNBG Recent Developments/Updates
Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai RAAS Major Business
Table 45. Shanghai RAAS Immune Globulin Intravenous Product and Services
Table 46. Shanghai RAAS Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Shanghai RAAS Recent Developments/Updates
Table 48. CBPO Basic Information, Manufacturing Base and Competitors
Table 49. CBPO Major Business
Table 50. CBPO Immune Globulin Intravenous Product and Services
Table 51. CBPO Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CBPO Recent Developments/Updates
Table 53. LFB Group Basic Information, Manufacturing Base and Competitors
Table 54. LFB Group Major Business
Table 55. LFB Group Immune Globulin Intravenous Product and Services
Table 56. LFB Group Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. LFB Group Recent Developments/Updates
Table 58. BPL Basic Information, Manufacturing Base and Competitors
Table 59. BPL Major Business
Table 60. BPL Immune Globulin Intravenous Product and Services
Table 61. BPL Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. BPL Recent Developments/Updates
Table 63. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 64. Sichuan Yuanda Shuyang Major Business
Table 65. Sichuan Yuanda Shuyang Immune Globulin Intravenous Product and Services
Table 66. Sichuan Yuanda Shuyang Immune Globulin Intravenous Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 68. Global Immune Globulin Intravenous Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 69. Global Immune Globulin Intravenous Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Immune Globulin Intravenous Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 71. Market Position of Manufacturers in Immune Globulin Intravenous, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Immune Globulin Intravenous Production Site of Key Manufacturer
Table 73. Immune Globulin Intravenous Market: Company Product Type Footprint
Table 74. Immune Globulin Intravenous Market: Company Product Application Footprint
Table 75. Immune Globulin Intravenous New Market Entrants and Barriers to Market Entry
Table 76. Immune Globulin Intravenous Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Immune Globulin Intravenous Sales Quantity by Region (2019-2024) & (K Units)
Table 78. Global Immune Globulin Intravenous Sales Quantity by Region (2025-2030) & (K Units)
Table 79. Global Immune Globulin Intravenous Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Immune Globulin Intravenous Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Immune Globulin Intravenous Average Price by Region (2019-2024) & (USD/Unit)
Table 82. Global Immune Globulin Intravenous Average Price by Region (2025-2030) & (USD/Unit)
Table 83. Global Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Global Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Global Immune Globulin Intravenous Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Immune Globulin Intravenous Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Immune Globulin Intravenous Average Price by Type (2019-2024) & (USD/Unit)
Table 88. Global Immune Globulin Intravenous Average Price by Type (2025-2030) & (USD/Unit)
Table 89. Global Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 90. Global Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 91. Global Immune Globulin Intravenous Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Immune Globulin Intravenous Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Immune Globulin Intravenous Average Price by Application (2019-2024) & (USD/Unit)
Table 94. Global Immune Globulin Intravenous Average Price by Application (2025-2030) & (USD/Unit)
Table 95. North America Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 96. North America Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 97. North America Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 98. North America Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 99. North America Immune Globulin Intravenous Sales Quantity by Country (2019-2024) & (K Units)
Table 100. North America Immune Globulin Intravenous Sales Quantity by Country (2025-2030) & (K Units)
Table 101. North America Immune Globulin Intravenous Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Immune Globulin Intravenous Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 104. Europe Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 105. Europe Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 106. Europe Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 107. Europe Immune Globulin Intravenous Sales Quantity by Country (2019-2024) & (K Units)
Table 108. Europe Immune Globulin Intravenous Sales Quantity by Country (2025-2030) & (K Units)
Table 109. Europe Immune Globulin Intravenous Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Immune Globulin Intravenous Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 112. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 113. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 114. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 115. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Region (2019-2024) & (K Units)
Table 116. Asia-Pacific Immune Globulin Intravenous Sales Quantity by Region (2025-2030) & (K Units)
Table 117. Asia-Pacific Immune Globulin Intravenous Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Immune Globulin Intravenous Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 120. South America Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 121. South America Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 122. South America Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 123. South America Immune Globulin Intravenous Sales Quantity by Country (2019-2024) & (K Units)
Table 124. South America Immune Globulin Intravenous Sales Quantity by Country (2025-2030) & (K Units)
Table 125. South America Immune Globulin Intravenous Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Immune Globulin Intravenous Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Type (2019-2024) & (K Units)
Table 128. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Type (2025-2030) & (K Units)
Table 129. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Application (2019-2024) & (K Units)
Table 130. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Application (2025-2030) & (K Units)
Table 131. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Region (2019-2024) & (K Units)
Table 132. Middle East & Africa Immune Globulin Intravenous Sales Quantity by Region (2025-2030) & (K Units)
Table 133. Middle East & Africa Immune Globulin Intravenous Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Immune Globulin Intravenous Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Immune Globulin Intravenous Raw Material
Table 136. Key Manufacturers of Immune Globulin Intravenous Raw Materials
Table 137. Immune Globulin Intravenous Typical Distributors
Table 138. Immune Globulin Intravenous Typical Customers
LIST OF FIGURES
Figure 1. Immune Globulin Intravenous Picture
Figure 2. Global Immune Globulin Intravenous Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Immune Globulin Intravenous Consumption Value Market Share by Type in 2023
Figure 4. IVIg Liquid Examples
Figure 5. IVIg Powder Examples
Figure 6. Global Immune Globulin Intravenous Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Immune Globulin Intravenous Consumption Value Market Share by Application in 2023
Figure 8. Immunodeficiency Examples
Figure 9. Autoimmune Disease Examples
Figure 10. Acute Infection Examples
Figure 11. Global Immune Globulin Intravenous Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Immune Globulin Intravenous Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Immune Globulin Intravenous Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Immune Globulin Intravenous Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Immune Globulin Intravenous Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Immune Globulin Intravenous Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Immune Globulin Intravenous by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Immune Globulin Intravenous Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Immune Globulin Intravenous Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Immune Globulin Intravenous Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Immune Globulin Intravenous Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Immune Globulin Intravenous Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Immune Globulin Intravenous Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Immune Globulin Intravenous Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Immune Globulin Intravenous Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Immune Globulin Intravenous Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Immune Globulin Intravenous Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Immune Globulin Intravenous Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Immune Globulin Intravenous Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Immune Globulin Intravenous Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Immune Globulin Intravenous Consumption Value Market Share by Region (2019-2030)
Figure 53. China Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Immune Globulin Intravenous Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Immune Globulin Intravenous Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Immune Globulin Intravenous Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Immune Globulin Intravenous Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Immune Globulin Intravenous Market Drivers
Figure 74. Immune Globulin Intravenous Market Restraints
Figure 75. Immune Globulin Intravenous Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Immune Globulin Intravenous in 2023
Figure 78. Manufacturing Process Analysis of Immune Globulin Intravenous
Figure 79. Immune Globulin Intravenous Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Immune Globulin Intravenous Picture
Figure 2. Global Immune Globulin Intravenous Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Immune Globulin Intravenous Consumption Value Market Share by Type in 2023
Figure 4. IVIg Liquid Examples
Figure 5. IVIg Powder Examples
Figure 6. Global Immune Globulin Intravenous Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Immune Globulin Intravenous Consumption Value Market Share by Application in 2023
Figure 8. Immunodeficiency Examples
Figure 9. Autoimmune Disease Examples
Figure 10. Acute Infection Examples
Figure 11. Global Immune Globulin Intravenous Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Immune Globulin Intravenous Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Immune Globulin Intravenous Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Immune Globulin Intravenous Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Immune Globulin Intravenous Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Immune Globulin Intravenous Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Immune Globulin Intravenous by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Immune Globulin Intravenous Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Immune Globulin Intravenous Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Immune Globulin Intravenous Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Immune Globulin Intravenous Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Immune Globulin Intravenous Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Immune Globulin Intravenous Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Immune Globulin Intravenous Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Immune Globulin Intravenous Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Immune Globulin Intravenous Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Immune Globulin Intravenous Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Immune Globulin Intravenous Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Immune Globulin Intravenous Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Immune Globulin Intravenous Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Immune Globulin Intravenous Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Immune Globulin Intravenous Consumption Value Market Share by Region (2019-2030)
Figure 53. China Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Immune Globulin Intravenous Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Immune Globulin Intravenous Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Immune Globulin Intravenous Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Immune Globulin Intravenous Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Immune Globulin Intravenous Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Immune Globulin Intravenous Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Immune Globulin Intravenous Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Immune Globulin Intravenous Market Drivers
Figure 74. Immune Globulin Intravenous Market Restraints
Figure 75. Immune Globulin Intravenous Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Immune Globulin Intravenous in 2023
Figure 78. Manufacturing Process Analysis of Immune Globulin Intravenous
Figure 79. Immune Globulin Intravenous Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
